Switch theme
Sign up to access all valuation multiples
New China Life Insurance is headquartered in Beijing and was established in 1996 by a combination of state-owned enterprises and private firms. It is currently the fourth-largest life insurer in China based on total assets. The company is partly owned by Huijin Investment, the government’s investment arm, which holds a 31% stake in New China Life. In 2011, the company was listed on both the Hong Kong and Shanghai stock exchanges.New China Life offers a wide range of life insurance products and services to both individual and institutional customers through its extensive distribution networks and diverse marketing channels. Additionally, it manages and invests insurance funds through its subsidiaries, including its Asset Management Company and Asset Management Company (Hong Kong).
1996
28.7K+
LTM Revenue $18.6B
LTM EBITDA $4.8B
$17.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
New China Life Insurance has a last 12-month revenue (LTM) of $18.6B and a last 12-month EBITDA of $4.8B.
In the most recent fiscal year, New China Life Insurance achieved revenue of $9.4B and an EBITDA of n/a.
New China Life Insurance expects next 12-month revenue of XXX and NTM EBITDA of XXX
See New China Life Insurance valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $18.6B | XXX | $9.4B | XXX | XXX | XXX |
| Gross Profit | $18.6B | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | n/a | XXX | XXX | XXX |
| EBITDA | $4.8B | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | n/a | XXX | XXX | XXX |
| EBIT | $3.7B | XXX | n/a | XXX | XXX | XXX |
| EBIT Margin | 20% | XXX | n/a | XXX | XXX | XXX |
| Net Profit | $3.3B | XXX | $3.6B | XXX | XXX | XXX |
| Net Margin | 18% | XXX | 39% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, New China Life Insurance's stock price is CNY 43 (or $6).
New China Life Insurance has current market cap of CNY 135B (or $18.8B), and EV of CNY 125B (or $17.4B).
See New China Life Insurance trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $17.4B | $18.8B | XXX | XXX | XXX | XXX | $1.07 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, New China Life Insurance has market cap of $18.8B and EV of $17.4B.
New China Life Insurance's trades at 1.8x EV/Revenue multiple, and n/a EV/EBITDA.
Equity research analysts estimate New China Life Insurance's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
New China Life Insurance has a P/E ratio of 5.6x.
See valuation multiples for New China Life Insurance and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $18.8B | XXX | $18.8B | XXX | XXX | XXX |
| EV (current) | $17.4B | XXX | $17.4B | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 3.6x | XXX | n/a | XXX | XXX | XXX |
| EV/EBIT | 4.7x | XXX | n/a | XXX | XXX | XXX |
| EV/Gross Profit | 0.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 5.6x | XXX | 5.2x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 1.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNew China Life Insurance's last 12 month revenue growth is 1%
New China Life Insurance's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged n/a for the same period.
New China Life Insurance's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
New China Life Insurance's rule of X is 28% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for New China Life Insurance and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 43% | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | -21% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 28% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| ADNIC | XXX | XXX | XXX | XXX | XXX | XXX |
| Aegon | XXX | XXX | XXX | XXX | XXX | XXX |
| ASR Nederland | XXX | XXX | XXX | XXX | XXX | XXX |
| NN Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Challenger | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
New China Life Insurance acquired XXX companies to date.
Last acquisition by New China Life Insurance was XXXXXXXX, XXXXX XXXXX XXXXXX . New China Life Insurance acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was New China Life Insurance founded? | New China Life Insurance was founded in 1996. |
| Where is New China Life Insurance headquartered? | New China Life Insurance is headquartered in China. |
| How many employees does New China Life Insurance have? | As of today, New China Life Insurance has 28.7K+ employees. |
| Is New China Life Insurance publicy listed? | Yes, New China Life Insurance is a public company listed on SHG. |
| What is the stock symbol of New China Life Insurance? | New China Life Insurance trades under 601336 ticker. |
| When did New China Life Insurance go public? | New China Life Insurance went public in 2011. |
| Who are competitors of New China Life Insurance? | Similar companies to New China Life Insurance include e.g. ADNIC, Aegon, ASR Nederland, NN Group. |
| What is the current market cap of New China Life Insurance? | New China Life Insurance's current market cap is $18.8B |
| What is the current revenue of New China Life Insurance? | New China Life Insurance's last 12 months revenue is $18.6B. |
| What is the current revenue growth of New China Life Insurance? | New China Life Insurance revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of New China Life Insurance? | Current revenue multiple of New China Life Insurance is 0.9x. |
| Is New China Life Insurance profitable? | Yes, New China Life Insurance is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of New China Life Insurance? | New China Life Insurance's last 12 months EBITDA is $4.8B. |
| What is New China Life Insurance's EBITDA margin? | New China Life Insurance's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of New China Life Insurance? | Current EBITDA multiple of New China Life Insurance is 3.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
